Gold tier: mechanically validated evidence, with its primary source.
298 evidence items · page 10 / 12
70.7 %70.7% of the female postgraduate students at the University of Ibadan preferred cervical cancer screenings to be done during antenatal clinic visits.
Nigeriacancer du col de l'utéruspublished 2024BMC women's healthPubMeddocument of 6 observations
93.3 %93.3% of the respondents were willing to undergo cervical cancer screening.
Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 13 observations
Cervical cancer is the second leading cause of female cancer deaths in Nigeria.
Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 13 observations
96.25 %Knowledge of HPV and cervical cancer among senior secondary school aged girls had a mean score of 96.25%.
Nigeriacancer du col de l'utérus · infection à HPVpublished 2022BMC public healthPubMeddocument of 6 observations
24 patientsTwenty-four patients were audited in the retrospective audit of the 3D-HDR-BT pilot program for cervical cancer in Lagos, Nigeria.
Nigeriacancer du col de l'utéruspublished 2025BrachytherapyPubMeddocument of 8 observations
21.6 %Less than one-third (21.6%) of those treated returned for post-treatment screening test.
Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations
2.06 scoreThe mean knowledge of cervical cancer was 2.06±0.55.
Nigeriacancer du col de l'utéruspublished 2020The Pan African medical journalPubMeddocument of 7 observations
4 %Only 4% of the respondents had their daughters vaccinated against HPV.
Nigeriacancer du col de l'utéruspublished 2020The Pan African medical journalPubMeddocument of 5 observations
Cervical cancer is the second highest cause of female cancer deaths in Nigeria.
Nigeriacancer du col de l'utéruspublished 2022BMC public healthPubMeddocument of 6 observations
76.71 %76.71% of the 790 respondents exhibited a high level of knowledge of cervical cancer, its causes, risk factors and prevention.
Nigeriacancer du col de l'utéruspublished 2024African health sciencesPubMeddocument of 5 observations
Invasive cervical cancer (ICC) is a serious public health burden in Nigeria, where human immunodeficiency virus (HIV) remains highly prevalent.
Nigeriacancer du col de l'utérus · VIH/sidapublished 2022Frontiers in public healthPubMeddocument of 4 observations
13.5 %Cervical cancer screening uptake was 13.5% among HIV-seronegative females.
Nigeriacancer du col de l'utéruspublished 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 8 observations
86 %Most women (86%) had a normal Pap smear at first cervical cancer screening at Jos University Teaching Hospital in Nigeria.
Nigeriacancer du col de l'utéruspublished 2024Cancer causes & control : CCCPubMeddocument of 5 observations
4.5 %4.5% of respondents had ever undergone cervical cancer screening in a community health outreach program in Ituku, Enugu State, Nigeria.
Nigeriacancer du col de l'utérusobserved 2024published 2026Rural and remote healthPubMeddocument of 8 observations
Women in low- and middle-income countries remain at high risk of developing cervical cancer.
Nigeriacancer du col de l'utéruspublished 2020International journal of health geographicsPubMeddocument of 4 observations
0.346 odds_ratioReligion was an independent predictor of lower brachytherapy utilization (p = 0.003, OR = 0.346, 95% CI = 0.171–0.701).
Nigeriacancer du col de l'utérusobserved March 2021 to June 2024PubMeddocument of 6 observations
77.2 %A majority of respondents (77.2%) had low knowledge of cervical cancer.
Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations
93.3 %93.3% of the 105 surveyed Nigerian gynecologists reported awareness of the SOGON clinical practice guidelines for cervical cancer prevention.
Nigeriacancer du col de l'utéruspublished 2025JMIR cancerPubMeddocument of 8 observations
58.1 %58.1% of the 105 surveyed Nigerian gynecologists reported integrating the SOGON clinical practice guidelines into routine clinical practice.
Nigeriacancer du col de l'utéruspublished 2025JMIR cancerPubMeddocument of 8 observations
45.2 %45.2% of rural women in North Central Nigeria had fair/good knowledge of cervical cancer screening.
Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations
50.5 %50.5% of the female postgraduate students at the University of Ibadan agreed that the benefits of cervical cancer screening outweigh the stress of the screening procedure.
Nigeriacancer du col de l'utéruspublished 2024BMC women's healthPubMeddocument of 6 observations
3.3 %Cervical cancer screening prevalence among women aged 30–49 years in Nigeria was 3.3% in the North East region.
Nigeriacancer du col de l'utérusobserved 2023–24PubMeddocument of 3 observations
Cervical cancer is the second leading cause of cancer-related deaths among women in Nigeria, after breast cancer.
Nigeriacancer du col de l'utéruspublished 2025Cancer control : journal of the Moffitt Cancer CenterPubMeddocument of 6 observations
Most cervical cancer cases occur in women aged 15–44 years.
Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations
Cervical cancer is a leading cause of cancer deaths among women in Nigeria.
Nigeriacancer du col de l'utéruspublished 2026JMIR formative researchPubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.